Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Basic science, rationale, background and future of abatacept

Highly Accessed Review

The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis

Eric M Ruderman* and Richard M Pope

Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25  doi:10.1186/ar1688


  • Last 30 days: 64 accesses
  • Last 365 days: 726 accesses
  • All time: 13799 accesses

Cited by

BioMed Central: 4 citations